Free Trial

Fractyl Health (GUTS) Competitors

Fractyl Health logo
$1.26 -0.02 (-1.56%)
Closing price 04/25/2025 04:00 PM Eastern
Extended Trading
$1.25 -0.01 (-0.40%)
As of 04/25/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GUTS vs. STIM, SMTI, ZIMV, RCEL, SNWV, NVRO, NYXH, ELMD, PDEX, and DRTS

Should you be buying Fractyl Health stock or one of its competitors? The main competitors of Fractyl Health include Neuronetics (STIM), Sanara MedTech (SMTI), ZimVie (ZIMV), AVITA Medical (RCEL), SANUWAVE Health (SNWV), Nevro (NVRO), Nyxoah (NYXH), Electromed (ELMD), Pro-Dex (PDEX), and Alpha Tau Medical (DRTS). These companies are all part of the "medical equipment" industry.

Fractyl Health vs.

Neuronetics (NASDAQ:STIM) and Fractyl Health (NASDAQ:GUTS) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk, media sentiment, earnings and community ranking.

Neuronetics received 124 more outperform votes than Fractyl Health when rated by MarketBeat users. However, 100.00% of users gave Fractyl Health an outperform vote while only 68.62% of users gave Neuronetics an outperform vote.

CompanyUnderperformOutperform
NeuroneticsOutperform Votes
129
68.62%
Underperform Votes
59
31.38%
Fractyl HealthOutperform Votes
5
100.00%
Underperform Votes
No Votes

53.6% of Neuronetics shares are owned by institutional investors. 9.8% of Neuronetics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Neuronetics has a net margin of -50.09% compared to Fractyl Health's net margin of -64,849.48%. Fractyl Health's return on equity of 0.00% beat Neuronetics' return on equity.

Company Net Margins Return on Equity Return on Assets
Neuronetics-50.09% -141.24% -32.77%
Fractyl Health -64,849.48%N/A -57.21%

Neuronetics has a beta of 1.97, meaning that its stock price is 97% more volatile than the S&P 500. Comparatively, Fractyl Health has a beta of 0.3, meaning that its stock price is 70% less volatile than the S&P 500.

Neuronetics presently has a consensus target price of $5.50, indicating a potential upside of 22.77%. Fractyl Health has a consensus target price of $11.00, indicating a potential upside of 773.02%. Given Fractyl Health's stronger consensus rating and higher probable upside, analysts clearly believe Fractyl Health is more favorable than Neuronetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Neuronetics
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Fractyl Health
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Neuronetics had 5 more articles in the media than Fractyl Health. MarketBeat recorded 6 mentions for Neuronetics and 1 mentions for Fractyl Health. Neuronetics' average media sentiment score of 0.41 beat Fractyl Health's score of 0.00 indicating that Neuronetics is being referred to more favorably in the media.

Company Overall Sentiment
Neuronetics Neutral
Fractyl Health Neutral

Neuronetics has higher revenue and earnings than Fractyl Health. Neuronetics is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Neuronetics$74.89M3.94-$30.19M-$1.37-3.27
Fractyl Health$93K662.79-$77.09M-$1.53-0.82

Summary

Neuronetics beats Fractyl Health on 11 of the 17 factors compared between the two stocks.

Get Fractyl Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GUTS vs. The Competition

MetricFractyl HealthSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$61.64M$4.29B$5.44B$7.80B
Dividend YieldN/A46.48%5.43%4.31%
P/E Ratio-0.1030.2922.1418.40
Price / Sales662.7952.50389.70101.29
Price / CashN/A51.0838.2034.62
Price / BookN/A6.096.664.18
Net Income-$77.09M$67.60M$3.21B$247.71M
7 Day Performance3.28%4.51%6.21%6.61%
1 Month Performance-0.79%-7.02%-2.82%-2.21%
1 Year Performance-81.19%27.14%16.44%4.68%

Fractyl Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GUTS
Fractyl Health
1.2714 of 5 stars
$1.26
-1.6%
$11.00
+773.0%
-81.3%$61.64M$93,000.00-0.10102
STIM
Neuronetics
1.2321 of 5 stars
$3.88
+3.2%
$5.50
+41.8%
+27.3%$255.36M$74.89M-3.15180
SMTI
Sanara MedTech
1.7965 of 5 stars
$28.66
-2.6%
$48.50
+69.2%
-1.5%$255.13M$86.67M-28.9560
ZIMV
ZimVie
2.6093 of 5 stars
$8.92
-5.0%
$19.50
+118.6%
-39.0%$248.40M$449.75M-0.682,700Positive News
RCEL
AVITA Medical
1.0858 of 5 stars
$9.10
-1.2%
$17.25
+89.6%
+21.3%$240.56M$64.25M-3.81130
SNWV
SANUWAVE Health
N/A$28.00
-6.6%
N/AN/A$239.37M$32.63M-7.1840
NVRO
Nevro
0.7213 of 5 stars
$5.85
+0.1%
$5.36
-8.3%
-49.6%$224.32M$408.52M-3.091,090Analyst Forecast
NYXH
Nyxoah
2.0321 of 5 stars
$5.94
-1.5%
$14.50
+144.1%
-48.0%$202.32M$4.52M-3.18110Gap Up
ELMD
Electromed
0.702 of 5 stars
$22.62
-0.7%
$38.00
+68.0%
+44.2%$193.56M$59.63M30.16160
PDEX
Pro-Dex
1.487 of 5 stars
$58.31
-4.1%
$52.00
-10.8%
+251.5%$190.15M$61.00M29.01140Upcoming Earnings
News Coverage
Positive News
DRTS
Alpha Tau Medical
2.8049 of 5 stars
$2.64
+2.7%
$8.00
+203.0%
+10.0%$185.81MN/A-6.1480

Related Companies and Tools


This page (NASDAQ:GUTS) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners